ask="3.89"
ask_size="600"
average_daily_volume="477618"
bid="3.62"
bid_size="900"
book_value="0.44"
change="+0.27"
change_from_200_day_moving_average="1.53"
change_from_50_day_moving_average="1.31"
change_from_52_week_high="-0.07"
change_From_52_week_low="2.51"
change_in_percent="+8.28%"
close="3.53"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.10"
ebitda="-24.72M"
eps_estimate_current_year="-1.13"
eps_estimate_next_quarter="-0.29"
eps_estimate_next_year="-0.94"
ex_dividend_date="N/A"
float_shares="20320000"
high="3.60"
high_52_weeks="3.60"
last_trade_date="2/28/2017"
last_trade_price="3.53"
last_trade_size="18039"
last_trade_time="4:00pm"
low="3.15"
low_52_weeks="1.02"
market_capitalization="82.77M"
moving_average_200_day="2.00"
moving_average_50_day="2.22"
name="CymaBay Therapeutics Inc."
notes="N/A"
one_year_target_price="5.67"
open="3.22"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+76.34%"
percent_change_from_50_day_moving_average="+59.31%"
percent_change_from_52_week_high="-1.94%"
percent_change_from_52_week_low="+246.08%"
previous_close="3.26"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.48"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="23447000"
short_ratio="0.45"
stock_exchange="NCM"
symbol="CBAY"
volume="843409"
weeks_range_52="1.02 - 3.60"
